new glp-1 agonist How medications are transforming diabetes and weight loss treatment Glucagon-like peptide-1 receptor: mechanisms and
Description
Are you a candidate?
Researchers are examining whether drugs currently approved to treat obesity and type 2 diabetes could be useful for a wider range of health challenges.
A reminder that their story doesnt start in Hollywood
Interestingly, this raises important points in regard to the need to hold GLP-1 RAs prior to concurrent EGD and colonoscopy procedures and the number of days needed to hold these agents, if necessary
